These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect on ovulation of 20 alpha-hydroxy-4-pregnen-3-one and its 5 alpha-reduced metabolites in immature rats treated with pregnant mare serum gonadotrophin.
    Author: Gilles PA, Karavolas HJ.
    Journal: J Endocrinol; 1981 Feb; 88(2):289-92. PubMed ID: 7205130.
    Abstract:
    The ability of 20 alpha-hydroxy-4-pregnen-3-one (20 alpha-dihydroprogesterone, 20 alpha-DHP) and its 5 alpha-reduced metabolites, 20 alpha-hydroxy-5 alpha-pregnan-3-one and 5 alpha-pregnane-3 alpha,20 alpha-diol, to facilitate ovulation was examined in immature female rats which had been treated on day 22 of age with a non-ovulatory dose (12 i.u.) of pregnant mare serum gonadotrophin. An increased incidence of ovulation occurred in rats treated on the morning of day 24 with 20 alpha-DHP. However, a dose of 20 alpha-DHP three to four times that of progesterone was required to induce ovulation in all animals. In contrast, neither 20 alpha-hydroxy-5 alpha-pregnan-3-one (at doses ranging from 0.5 to 5.0 mg) nor 5 alpha-pregnane-3 alpha,20 alpha-diol (tested at 3.0 or 4.0 mg) facilitated ovulation. Therefore both 20 alpha-DHP and progesterone, the two major progestins of the rat oestrous cycle, have the ability to facilitate ovulation. It is concluded that the ability of 20 alpha-DHP to facilitate ovulation does not appear to be by way of conversion to its 5 alpha-reduced metabolites.
    [Abstract] [Full Text] [Related] [New Search]